Science Explorer Interactive view Map
Company · New York · United States

Enzo Biochem (United States)

Research works
32
▲ 236% vs 2013–17
Citations
1.1k
34.5 per fractional work
Top-10% rate
46.5%
record average 16.5%
Open access
30%
world 28%

Not ranked overall: Enzo Biochem (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Enzo Biochem (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Vaccine, Immune Response, Nanoparticles, Pathogenesis, Treatment, Antiviral Therapy and DNA nanotechnology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Epidemiology5▲ 3.9×15 topics
  2. Vaccine3▲ 26×6 topics
  3. Immune Response3▲ 16×6 topics
  4. Nanoparticles3▲ 6.3×2 topics
  5. Treatment2▲ 4.9×6 topics
  6. Oxidative Stress2▲ 3.1×4 topics
  7. Pathogenesis2▲ 10×4 topics
  8. Antiviral Therapy2▲ 33×3 topics
  9. Inflammation2▲ 2.1×6 topics
  10. DNA nanotechnology2▲ 46×1 topic
  11. NK Cell Recognition2▲ 46×1 topic
  12. Natural Killer Cells2▲ 46×1 topic
  13. Self-Assembly2▲ 12×1 topic
  14. Immunity1▲ 13×2 topics
  15. Hepatocellular Carcinoma1▲ 18×3 topics
  16. Infection1▲ 15×3 topics
  17. Liver Disease1▲ 29×2 topics
  18. Diagnosis1▲ 3.8×4 topics
  19. Ecology1▲ 18×1 topic
  20. Food Safety1▲ 14×2 topics
  21. Microbiome1▲ 27×2 topics
  22. Virus1▲ 30×1 topic
  23. Gene Therapy1▲ 13×3 topics
  24. Life Cycle Assessment1▲ 20×2 topics
  25. Molecular Characterization1▲ 18×2 topics
  26. Antiretroviral Therapy1▲ 14×2 topics
  27. Biotin1▲ 184×1 topic
  28. Carnosine1▲ 87×1 topic
  29. Cronobacter sakazakii1▲ 341×1 topic
  30. Enterobacteriaceae1▲ 341×1 topic
  31. Laser Eye Injuries1▲ 161×1 topic
  32. Photovoltaic Systems1▲ 47×1 topic
  33. Proximity Labeling1▲ 184×1 topic
  34. Retinal Damage1▲ 161×1 topic
  35. Solar Energy1▲ 17×1 topic
  36. ß-Alanine Supplementation1▲ 87×1 topic

Which research topics does Enzo Biochem (United States) publish most on?

By volume in 2022–2025: Retinal Diseases and Treatments, Cancer survivorship and care, Prostate Cancer Diagnosis and Treatment and Retinal and Optic Conditions.

  1. 1 Retinal Diseases and Treatments Ophthalmology 0 works
  2. 2 Cancer survivorship and care Oncology 0 works
  3. 3 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  4. 4 Retinal and Optic Conditions Ophthalmology 0 works
  5. 5 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  6. 6 Retinal Development and Disorders Molecular Biology 0 works
  7. 7 Ocular Diseases and Behçet’s Syndrome Ophthalmology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.5%not open69.5%

World: 28% of research is openly available.

with international co-authors34.9%domestic only65.1%

World: 19% is written across borders.

How has Enzo Biochem (United States)'s research output changed?

Output in 2018–2022 was 236% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New York

All research institutions in New York

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.